CombiGene AB (publ) (“CombiGene”, “the Company”) announces today that it intends to sharpen its strategic focus
CombiGene AB (publ) (“CombiGene”, the “Company”) today announces preliminary results from completed analyzes of the latest
CombiGene AB (publ) (“CombiGene”, the “Company”) announces today that Västra Hamnen Corporate Finance, in its initial
CombiGene AB (publ) (“CombiGene”, “the Company”) today announces that the Company has entered into a license
CombiGene AB (publ) (“CombiGene”, the “Company”) announces today that the company intends to change Certified Adviser
CombiGene AB (publ) (“CombiGene”, the “Company”) announces today that Annika Ericsson, current Director Preclinical Development, will
The following resolutions were passed at the Annual General Meeting (the “AGM”) of CombiGene AB (publ)
N.B. The below is an unofficial translation of the Swedish original, in case of any discrepancies
CombiGene AB (publ) (“CombiGene”, the “Company”) today announces that the patent offices in Australia and India
CombiGene AB (publ) (“CombiGene”, “the Company”) today announces that the Danish company Orphazyme gradually has acquired